Spectrin a2 (aII-spectrin) is a scaffolding protein encoded by the Spna2 gene and constitutively expressed in most tissues. Exon trapping of Spna2 in C57BL/6 mice allowed targeted disruption of aII-spectrin. Heterozygous animals displayed no phenotype by 2 years of age. Homozygous deletion of Spna2 was embryonic lethal at embryonic day 12.5 to 16.5 with retarded intrauterine growth, and craniofacial, neural tube and cardiac anomalies. The loss of aII-spectrin did not alter the levels of aI-or bI-spectrin, or the transcriptional levels of any b-spectrin or any ankyrin, but secondarily reduced by about 80% the steady state protein levels of bII-and bIII-spectrin. Residual bII-and bIII-spectrin and ankyrins B and G were concentrated at the apical membrane of bronchial and renal epithelial cells, without impacting cell morphology. Neuroepithelial cells in the developing brain were more concentrated and more proliferative in the ventricular zone than normal; axon formation was also impaired. Embryonic fibroblasts cultured on fibronectin from E14.5 (Spna2 2/2 ) animals displayed impaired growth and spreading, a spiky morphology, and sparse lamellipodia without cortical actin. These data indicate that the spectrin-ankyrin scaffold is crucial in vertebrates for cell spreading, tissue patterning and organ development, particularly in the developing brain and heart, but is not required for cell viability.
Introduction
Spectrin a2 (aII-spectrin) is a 285 kDa scaffolding protein abundant in most eukaryotic cells. Three decades of study have implicated the spectrin heterodimer formed between aII-spectrin and any of five b-spectrins in a bewildering array of cellular processes. These include a role in the formation and maintenance of specialized plasma membrane domains defining apicalbasolateral and planar polarity in epithelial cells, muscle and neurons (Bennett and Baines, 2001) ; in the structural support of the plasma membrane and the maintenance of cell shape (Gallagher and Jarolim, 2000; Kizhatil et al., 2007) ; as a scaffold upon which calcium-mediated and tyrosine kinase-phosphatase signal transduction pathways converge (Nicolas et al., 2002; Nedrelow et al., 2003) ; as a tumor-suppressor protein involved in TGF-b-SMAD regulation (Tang et al., 2003) ; as a cargo selection mechanism in the secretory and endocytic pathways (De Matteis and Morrow, 2000) ; as a regulator of macropinocytosis (Xu et al., 2000) ; as a tether linking trafficking vesicles to microtubule motors (Holleran et al., 2001; Muresan et al., 2001) ; as a nuclear scaffold organizer (McMahon et al., 1999; Tse et al., 2001) ; and most recently, as a potential mechano-sensing ligand-binding switch (Stabach et al., 2009 ). Deletion of aII-spectrin in Drosophila melanogaster and Caenorhabditis elegans leads to late embryonic-early larval stage lethality (Moorthy et al., 2000; Dubreuil, 2006; Hammarlund et al., 2007) , and recent knockdown studies of aII-spectrin in cultured cells have demonstrated growth and adhesion defects (Metral et al., 2009) . However, the role of aII-spectrin in vertebrate development remains unexplored.
We have achieved targeted disruption of aII-spectrin in C57/B6 mice by the insertion of a foreign exon encoding b-galactosidase (b-gal) into the murine Spna2 gene. The resulting gene product is a short-lived and non-functional fusion protein that includes the N-terminal half of aII-spectrin fused to b-gal. Heterozygous animals (Spna2 +/2 ) display no phenotype by 2 years of age. Homozygous animals die in utero. Embryos lacking wild-type aII-spectrin (Spna2 2/2 ) are smaller than normal, survive to embryonic day 12.5 (E12.5), but then die due to malformations of the neural tube and cardiac systems. Thus, aII spectrin is required in vivo for late embryonic development. The cell biological consequences of its loss include instability of its cognate partners (bII-and bIIIspectrin); impaired membrane biogenesis and sorting of not only the cortical actin skeleton, but also of ankyrins B and G; and modification of pathways regulating cell spreading and growth. Conversely, spectrin loss in vivo does not affect epithelial cell shape, stability or nuclear morphology, nor is it required for cell viability. These findings have several implications for the potential role of aII-spectrin in human disease.
Results
Loss of aII-spectrin leads to a concomitant loss of two b-spectrins and selected ankyrins PCR analysis of murine tissues derived from ES RRQ171 identified the locus of the b-geo exon trap (encoding a b-galneomycin resistance fusion protein) within the intron between exons 24 and 25 of the spectrin Spna2 gene (Fig. 1A) . The exontrapped gene generates a spectrin b-gal fusion message that truncates the aII-spectrin gene product at codon 1153, corresponding to a polypeptide terminating within spectrin repeat ten, lacking the C-terminal site responsible for heterodimer formation with b-spectrin (Li et al., 2008) . In tissues or cells homozygous for this insertion (Fig. 1B) , mRNA encoding aII-spectrin was undetectable when probed by realtime (RT)-PCR for sequences downstream of b-geo, but not when primers upstream of exon 24 were utilized (Fig. 1C) . Correspondingly, western blot analysis showed that Spna2 2/2 embryos did not react with aII-spectrin antibodies directed to epitopes downstream of the exon trap, whereas antibodies directed to epitopes upstream of the exon trap reacted with a band at about 260,000 relative molecular mass (Fig. 1D ). This band also reacted with antibodies against b-gal, confirming its identity as a fusion product between aII-spectrin exons 1-24 and b-gal. Analysis of whole embryos for the expression of either the wild-type gene or the exon-trapped gene revealed no significant differences, with both being widely expressed and most highly expressed in the nervous system (supplementary material Fig. S1 ). By densitometry analysis, the ratio of the spectrin-bgal fusion protein in Spna2 2/2 mice to aII-spectrin in wild-type embryos (normalized to actin) was 0.21±0.03 (±1 s.d. arbitrary units). Analysis of mRNA levels indicated that the mRNA for wild-type aII-spectrin and the mRNA for the fusion product were expressed at equal levels (Fig. 2B) . Thus, the spectrin-b-gal fusion protein must be unstable relative to the wild-type protein; and the transcription level of mRNA encoding aII-spectrin is not responsive to the loss of the mature protein.
Also of interest was the fate of other proteins that are typically tightly associated with aII-spectrin, specifically spectrins bII and bIII, and ankyrins R, G, and B. Whole embryo levels of bII-and bIII-spectrin were reduced to below 20% of normal in the absence of aII-spectrin ( Fig. 2A) , with no change in their level of mRNA expression (Fig. 2B ). This finding is consistent with earlier studies in vertebrates demonstrating that b-spectrin is degraded if not assembled with a-spectrin (Woods and Lazarides, 1985; Hanspal and Palek, 1987) , and also indicates an absence of direct feedback control on the levels of b-spectrin expression. The level of spectrins aI and bI, forms predominantly (albeit not exclusively) expressed in erythrocytes, were unchanged in the Spna2 2/2 mice, at either the protein or mRNA level. Neither of the two remaining spectrins (bIV and bV) were expressed by E14.5 at sufficient levels to enable their reliable detection, so the impact of aII-spectrin loss on the disposition of these proteins was not evaluated.
Ankyrin expression and accumulation was less severely perturbed compared with the spectrins, but the reductions were (D) Western blot analysis showed that monoclonal antibodies to aII-spectrin (aII-C) that react with peptide sequences downstream of the exon trap were negative in homozygotes. Pan-reactive anti-spectrin antibodies (aII-pan) detect the fusion protein. Antibodies to b-gal confirm the presence of the fusion protein in both the homoand heterozygotes. still significant ( Fig. 2A,C) . The protein levels of AnkG190 (P,0.005) and AnkB440/220 (P,0.05) were slightly reduced and no significant changes in levels of mRNA encoding ankyrin were detected. The overall levels of VASP (Bournier et al., 2006) , Abi (Hssh3bp1) (Ziemnicka-Kotula et al., 1998) , Kap3 (Takeda et al., 2000) , and 14-3-3 (Ramser et al., 2010) , proteins that directly bind aIIbII-spectrin, were unchanged (supplementary material Fig. S2 ).
aII-spectrin deficiency is embryonic lethal, with cardiac, craniofacial and neural tube malformations
The loss of aII-spectrin is embryonic lethal. Of 18 litters generating 127 C57BL/6 mice in matings between heterozygous Spna2 +/2 pairs, 68 heterozygous and 27 homozygous wild-type mice were produced. No homozygous Spna2 2/2 mice were born. Heterozygous (Spna2 +/2 ) mice were morphologically indistinguishable from wild-type animals. Thus, one normal Spna2 allele was sufficient and generated normal levels of aII-spectrin (Fig. 1) .
Examination of the homozygous embryos at different gestational ages indicated that most (but not all) such embryos were still viable at E12.5, but that all had died by E16.5; thus the loss of aII-spectrin causes embryonic death between E12.5 and E16.5. Homozygous embryos exhibited intrauterine growth retardation; the average length of the Spna2 2/2 embryo at E11.5 was approximately 5.5 mm, and 7.0 mm for wild-type littermates. Whole-mount examination of heterozygous embryos revealed widespread expression of aII-spectrin throughout most tissues, but most concentrated in the heart and nervous system. The expression pattern of the mutant aII-spectrin-b-gal fusion allele was similar to that of the wild-type protein (supplementary material Fig. S1 ).
Accompanying the lethal phenotype of the Spna2 2/2 animals were several gross morphologic abnormalities (Fig. 3) . Although not every homozygous embryo showed every abnormality, typical features associated with the Spna2 2/2 embryos included craniofacial abnormalities with incomplete neural tube closure; abnormal dilatation of the primary brain vesicles, constriction of the mesencephalic vesicle, along with lateral ventricle and forebrain anomalies (Fig. 3B) . Outside the nervous system, aIIspectrin-deficient animals exhibited abnormal cardiac shape, cardiac dilatation, and thinning of the compact myocardium The loss of aII-spectrin reduced the steady state levels of bII-and bIII-spectrin to below 20% of normal; aI-and bI-spectrin were unchanged. The abundance of bIV-and bV-spectrin was too low in embryos younger than E14.5 to be reliably evaluated. Ankyrins B440 and G190 were both significantly diminished, as were ankyrins B220 and B150, albeit not to the same degree as the b-spectrins. (B,C) Quantitative RT-PCR analysis revealed that despite the change in protein levels, there were no consistent changes in the mRNA levels of any spectrin or ankyrin (except for the disrupted Spna2 gene, as measured with primers targeted to the 39 end, aII-39). Each analysis was performed in triplicate on two or three separate animals. Error bars show ±1 s.d. **P,0.05, ***P,0.005.
Deletion of aII-spectrin 3 (Fig. 3C ). The cardiac changes probably initiated the embryonic lethality, and were reminiscent of cardiac phenotypes observed following the disruption of TGF-b-Smad signaling (Qi et al., 2007) or following the loss of proteins that regulate actin dynamics such as Ena/VASP (Eigenthaler et al., 2003) . Interestingly, both TGF-b-Smad signaling (Tang et al., 2003) and Ena/VASP (Bournier et al., 2006) interact with spectrin, although the levels of neither Ena/VASP (supplementary material Fig. S2 ) nor the Smad proteins (supplementary material Fig. S3 ) were altered in the Spna2 2/2 embryos (see Discussion). Two unique cardiac embryonic isoforms of aII-spectrin (aIIS9 and aIIS10 ) that arise by alternative splicing have also been recently reported (Zhang et al., 2010) . In cell culture, these isoforms promote myocyte growth, suggesting that their loss in the Spna2 2/2 animals is consistent with the cardiac phenotype observed. Finally, the cardiac changes appear not to be secondary to failed hematopoiesis because the embryonic blood islands appeared normal and the embryos were pink and well oxygenated.
At the histological level, Spna2 2/2 animals displayed changes in the density of neuroepithelial cells along the ventricular zone (VZ) of the developing brain (Fig. 4A,B ). This is a region of active neuronal and glial differentiation; cells from this zone normally proliferate and migrate apical to populate overlying layers (Gotz and Huttner, 2005) . At about E13.5, earlier work has demonstrated that bII-spectrin and ankyrin B mark axonal sprouts in developing neuroblasts, whereas ankyrin G is a reliable marker of nascent axonal initial segments (Tang et al., 2002) . These distributions can be appreciated in the Spna2 +/+ animals, as shown in Fig. 4B . In the spectrin-deficient animals, these markers became restricted to an area near the soma, and the developing axonal sprouts and initial axon segments were diminished in abundance, a finding also supported by the reduced tau staining revealed in Fig. 4C . These animals also displayed enhanced nuclear density in the subventricular zone (SVZ), with more cells in the Spna2 2/2 animals staining positive for the proliferation marker Ki67 (34±11% vs 46±8%, P,0.006). There was no change in the level of apoptosis (as measured by TUNEL staining; Fig. 4C ). Beyond greater cellular proliferation, and given the impaired cellular spreading and movement of aIIspectrin-deficient cells described below and by others (Metral et al., 2009) , the enhanced cellular density apparent in the VZ and SVZ of the Spna2 2/2 animals could also arise from a failure of interkinetic movement of nuclei in the neuroepithelial cells of this zone, a feature related to cellular proliferation and responsible for the pseudostratified appearance of nuclei in the VZ (Gotz and Huttner, 2005) . Finally, using tau as a marker of axonal processes, it is apparent that aII-spectrin deficiency impaired axon formation and/or axon guidance in the VZ (Fig. 4C ). Tau-positive axons were shorter, less ordered, and often truncated at or near the soma in these animals. In this same area in the spectrin-deficient animals there was enhanced vimentin staining, a marker of glia, (supplementary material Fig. S4 ), suggesting that, as with the loss of bII-spectrin, aIIspectrin deficiency altered the program of neuroepithelial cell differentiation (Golestaneh et al., 2006) . Earlier work has 
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demonstrated that the micro-injection of anti-spectrin antibodies can lead to a condensation of the vimentin network (Mangeat and Burridge, 1984) . It will thus be of interest in future studies to carefully examine the vimentin network in cultured spectrindeficient cells because alterations in vimentin might contribute to some of the cell growth and phenotypic changes observed.
In contrast to the histological changes apparent in the brain, no histological anomalies were detected in E13.5 embryos in several other tissues. Sections of the developing kidney and lung are shown in Fig. 4A ,D. Although spectrin and ankyrin presumably play a role in providing structural support to the plasma membrane, and their absence in erythrocytes (Gallagher and Jarolim, 2000) and isolated bronchial cells (Kizhatil et al., 2007) leads to profound cell-shape change, the loss of aII-spectrin (with concomitant loss of bII-and bIII-spectrin) resulted in no significant change in epithelial cell layer thickness or epithelial cell shape (Fig. 4D) . Quantitative evaluation of cells with welldefined borders found no significant differences in cell height The VZ and SVZ of the developing brain display significant histological changes. Wild-type embryos at this stage of development display a thick pseudostratified VZ with active upward migration and population of overlying layers from the SVZ. In the Spna2 2/2 animals, the VZ was more compact, with fewer cells filling the more superficial layers (boxed area, shown enlarged in B). Other organs revealed no significant histological changes; kidney and lung are shown. In these organs, tubules and bronchioles were developing normally. (B) Enlargement of area outlined in A. In wild-type animals, aII-and bII-spectrin are rich in axon bundles (boxed) and are also present at synaptic terminals and initial axon segments (arrows). Ankyrin B is associated with unmyelinated axonal processes in the embryonic mouse (Chan et al., 1993) , whereas ankyrin G is found along axons and in dendrites and concentrates in the initial axon segments (Kordeli et al., 1995) . The loss of aII-spectrin disrupts the localization of these proteins, especially along the axon bundles, which no longer are marked by either spectrin or ankyrin. (C) Top two rows: Staining of sections with anti-tau demonstrates developing axon bundles in the VZ. Magnified images (36) of the boxed areas are shown on the right with inverse contrast. Note the foreshortened, sparse and more disordered axon segments and increased concentration of tau near the soma when aII-spectrin is disrupted. Bottom two rows: Immunostaining for Ki67, a proliferation marker, reveals increased proliferation with spectrin loss. Averaged over multiple fields, and scoring any detected Ki67 staining as positive, 34±11% of cells in the wildtype animals were positive as compared with 46±8% of the cells in the spectrin-deleted animals. This represents a highly significant (P,0.006) 35% increase in proliferative activity. TUNEL staining (right) reveals no change in the level of apoptosis. (D) Higher power views of developing renal tubules and lung bronchioles indicate preservation of epithelial morphology. Comparison of epithelial cell height reveals no changes, even without laterally associated spectrin or ankyrin (see Fig. 5 ).
Deletion of aII-spectrin 5 Spectrin loss causes a redistribution of bII-and bIII-spectrin and ankyrin
The loss of aII-spectrin perturbs the levels and distribution of its associated proteins. In the VZ at E13.5, aII-and bII-spectrin normally are found along the developing axon bundles (Fig. 4B) . Ankyrins B and G display a similar distribution, while ankyrin G also concentrates in the initial axon segments. In the absence of aII-spectrin, bII-spectrin and ankyrin B are lost from the unmyelinated axonal processes and ankyrin G is no longer concentrated at initial segments. Cells outside the nervous system also show a redistribution of the proteins normally associated with aII-spectrin, although apical-basolateral polarity is retained. Results with kidney tubules and lung bronchioles are shown (Fig. 5) . As expected, in the Spna2 2/2 animals, there was no immunostaining of tissues with antibodies directed to the C-terminal portions of aII-spectrin (Fig. 5A) . When antibodies were used that recognize the spectrin portions of the spectrin-b-gal fusion, or with b-gal antibodies, the fusion product was found concentrated along the apical membrane and submembrane in epithelial cells, a distribution unlike normal aII-spectrin (that surrounds the entire membrane). Interestingly, both distributions were apparent in heterozygous animals, suggesting that the fusion protein distributes independently of and has no effect on normal spectrin. This was also apparent when cell extracts were sedimented (Fig. 5A) . In wild-type or heterozygous animals, aII-spectrin sedimented as a large multiprotein complex near 13S, as did bII-spectrin. In animals without aII-spectrin, the residual bII-spectrin sedimented near 8S, indicating that it is no longer retained in a high molecular weight multiprotein complex.
The bII-and bIII-spectrin that remained in the renal tubules and lung bronchioles was largely redistributed to an apical submembranous compartment, coincident with the aII-spectrinb-gal fusion protein (Fig. 5B) . Ankyrin G displays the same redistribution; ankyrins B and R are only very weakly expressed in these cells at this stage of development and did not stain reliably. A consideration in these results is whether the absence of intact aII-spectrin per se is the driving force for protein redistribution, or whether it is an epiphenomenon due to a strong sorting determinant on the aII-spectrin-b-gal fusion protein present in these cells. Although we cannot formally exclude this possibility, we do not favor it, given the normal distribution of bII-spectrin and ankyrins in the heterozygote (data not shown). ) embryos, as detected by both the C-terminal anti-aII-spectrin antibody (aII-C) as well as the pan-reactive spectrin antibody (aII-pan). In the Spna2 2/2 tubules, the residual spectrin-b-gal fusion protein is totally lost from the basolateral membrane, and concentrated in coarse apical and sub-apical pools as detected by both aII-pan and by an antibody to b-gal. In heterozygotes (Spna2 +/2 ), the presence of the fusion protein had no detectable effect on the distribution of wild-type aII-spectrin, nor was the distribution of the fusion protein changed by the presence of aII-spectrin. Below: Sucrose density gradient analysis of proteins extracted from E13.5 embryos. In the homozygote (Spna2 2/2 ), bII-spectrin does not sediment with the high molecular weight protein complex at 13S. (B) Immunofluorescent micrographs of bronchioles and renal tubules. Without intact aIIspectrin, bII-and bIII-spectrin and ankyrin G are largely absent from the lateral membrane of both renal and bronchiole epithelial cells. Residual bII-and bIIIspectrin and ankyrin G concentrate instead at the apical membrane in a pattern similar to that of the aII-spectrin-b-gal fusion protein.
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We also note that in Drosophila, the genetic loss of a-spectrin leads to a redistribution and mislocalization of b-spectrin (Garbe et al., 2007) .
Growth and cell spreading is impaired in Spna2
2/2 MEFs
To determine the effect of spectrin loss on cellular actin and cell shape, the morphology of mouse embryonic fibroblasts (MEF) cultured from the Spna2 2/2 animals at E14.5 was compared with wild-type cells harvested from matched littermates. MEFs were plated on fibronectin and after 60 minutes, wild-type MEFs displayed a spread and flattened cell shape, with cortical and perinuclear actin bundles and frequent lamellipodia that were rich in both actin and aII-spectrin (Fig. 6A-C) . The aII-spectrin null MEFs spread more slowly, and after 0.5-3 hours in culture, displayed many filopodia and stress fibers, but few lamellipodia, giving them a rounded and spiky appearance (Fig. 6D ). These cells also lost their cortical actin ring, as well as the actin pools surrounding the nucleus. This phenotype was rescued by transfection with wild-type EYFP-tagged aII-spectrin, with restoration of a spread morphology, ruffling edge, and cortical actin ( Fig. 6E-H) . The expressed EYFP-aII-spectrin was apparent in the rescued cells at the ruffling edge and in lamellipodia, in a pattern similar to spectrin in wild-type cells (arrows, Fig. 6F,H) . The spread area of the aII-spectrin-deficient MEFs was on average only 32.2±20% of the area of the wild-type cells (Fig. 6, scattergram) . This result was highly significant (P51.6610 216 by ANOVA). This effect on cell spreading and size was completely rescued by transfection with EYFP-aIIspectrin.
Surprisingly given the enhanced Ki67 labeling observed in the brain of the mouse embryos, MEFs lacking aII-spectrin grew more slowly than did wild-type cells (Fig. 6, bottom) . This reduction in cell proliferation was not due to increased apoptosis or oncosis because the fraction of unfixed cells permeant to propidium iodide or the level of annexin V staining was unchanged between wildtype and spectrin deficient cells (data not shown). Whereas the basis for this difference between in vivo proliferation and that observed in culture is unknown, these findings do point to a potentially significant role for spectrin in modulating the signals that control cell growth and differentiation. Deletion of aII-spectrin 7
Discussion
Exon trapping has been used to generate a strain of mice devoid of functional aII-spectrin. These mice display uniform embryonic lethality at E12.5 to E16.5, with gross craniofacial, neurodevelopmental and cardiac defects. Detailed analysis reveals: (1) no compensation by aI-spectrin for the loss of aIIspectrin; (2) a reduction of bII-and bIII-spectrin to about 20% of normal levels due to accelerated degradation, with no change in their mRNA levels; (3) no apparent hematological anomalies that might contribute to the cardiovascular defects; (4) preserved epithelial cell morphology in renal tubules and bronchial epithelium; (5) mis-sorting of residual bII-and bIII-spectrin and ankyrin G in epithelial cells of the kidney and lung, away from the basolateral membrane to an apical compartment; (6) abnormal cellularization of the ventricular zone of the developing brain, with impaired axon formation; and (7) impaired spreading and lamellipodia formation, and reduced proliferation, in MEF cells cultured from aII-spectrin-deficient animals. The phenotype observed in these animals is very similar, although not an exact phenocopy, to that observed in mice deficient in bII-spectrin (termed ELF in those studies) (Mishra et al., 1999; Tang et al., 2003; Golestaneh et al., 2006) . The loss of bII-spectrin appears to disrupt growth and differentiation control via the TGF-b and Smad signaling pathways, and in this context bII-spectrin acts as a Smad3/4 adapter tethering these proteins to TFG-b receptors at the membrane (Tang et al., 2003) . Given that the loss of aII-spectrin leads to a secondary loss of most bII-(and bIII)-spectrin, it is tempting to attribute the phenotype of the aII-spectrin null animals to a disruption of bIIspectrin. However, several features of the Spna2 2/2 animals indicate that their phenotype is subtly different.
The loss of TGF-b signaling in bII-spectrin null animals leads to not only cardiac and neurological defects, but also to intrahepatic biliary tree anomalies and the late onset of gastrointestinal and hepatic tumors in heterozygotes (Tang et al., 2005) . The aII-spectrin mutant animals display no hepatic anomalies, at least during early embryonic development, and after 2 years the heterozygotes show no propensity to tumor formation. Similarly, both the aII-and bIIspectrin null animals display disrupted neuroepithelial cell compaction in the ventricular zone (Golestaneh et al., 2006) and both display an exaggerated proliferation of neuroepithelial precursors, suggesting that aII-spectrin-deficient animals might also harbor a defect in TGF-b-mediated cell differentiation. Although this result might be expected based on the reduced levels of bII-spectrin that follow the loss of aII-spectrin, we have so far been unable to demonstrate any changes in Smad2/3 levels or in their levels of phosphorylation in aII-spectrin-deficient animals or cells (supplementary material Fig. S3 ). Thus, possibly only low levels of residual bII-spectrin are sufficient to maintain TGF-b-Smad signaling pathways. This result would imply that bII-spectrin can function autonomously from aII-spectrin. There is some evidence for autonomous b-spectrin function, beginning with early observations of homopolymeric b-spectrin associated with the neuromuscular junction (Bloch and Morrow, 1989; Pumplin, 1995) , and further supported by studies in Drosophila that have revealed persistent b-spectrin function in axonal pathfinding that is partially independent of a-spectrin (Garbe et al., 2007; Hulsmeier et al., 2007) .
Alternatively, other changes more specific for aII-spectrin might be the genesis of the observed changes in the heart and brain. In many respects, the aII-spectrin null animals appear similar to those with deletion of n-cofilin (Bellenchi et al., 2007) , which causes impaired radial migration and early compaction of the VZ due to an early exit of progenitor cells from the proliferating pool. Impaired spreading (and impaired lamellipodia formation) is a major consequence of aII-spectrin deficiency in the isolated cell culture studies reported here, as well as in earlier aII-spectrin knockdown studies (Metral et al., 2009) . aII-spectrin was also found to interact via its SH3 domain with EVL/VASP, an actin regulator (Bournier et al., 2006) . The importance of actin dynamics as a regulator of radial migration from the VZ is also supported by the observation that mutations in filamin A (another actin-binding protein) profoundly affect neuroepithelial polarity and migration from the VZ (Sato and Nagano, 2005) . Thus, we speculate that the subtle phenotypic differences observed between the deletion of aII-spectrin and bIIspectrin reflects in part, a more widespread disruption of actin dynamics, with perhaps less contributions from impaired TGF-bSmad signaling.
The ab-spectrin heterotetramer also has other putative functions beyond actin binding that might contribute to the phenotype of its deficiency. The SH3 domain of aII-spectrin is involved in macropinocytosis (Xu et al., 2000) and cell signaling; it binds both non-receptor tyrosine kinases of the c-src family (Nedrelow et al., 2003) and tyrosine phosphatases (Lecomte et al., 2001 ). The tyrosine phosphorylation of spectrin blocks its cleavage by calpain (Nicolas et al., 2002; Nedrelow et al., 2003) , an effect also modulated by Ca 2+ and calmodulin (Harris and Morrow, 1990) . Spectrin participates in the activation of the Rho GTPase Rac, and overexpression of the aII-spectrin SH3 domain inhibits Rac1 activation, actin filament formation, and cell spreading in cultured cells (Bialkowska et al., 2005) . Interestingly, actin and Rac1 have also been implicated in the regulation of neuronal polarity and axon formation via the WAVE complex (Tahirovic et al., 2010) , and the loss of Rac1 in neural crest cells leads to severe craniofacial and cardiovascular malformations (Thomas et al., 2010) . We thus anticipate that a major effector pathway disrupted in the Spna2 2/2 animals will be Rac-mediated actin regulation.
A third aspect of spectrin's function that might contribute to the observed phenotype is its participation as a membrane stabilizer. Studies in C. elegans (Hammarlund et al., 2007) and Drosophila (Garbe et al., 2007; Hulsmeier et al., 2007) demonstrate aberrant neurite development and axon guidance, and (in the case of C. elegans) frequent axonal breaks with chaotic repair in spectrin-deficient animals (Hammarlund et al., 2007) . These observations build on the classical view of the spectrin skeleton as a stabilizing and organizing infrastructure. However, the evidence for this process in vertebrate nonerythroid cells is scant. Only in mammalian erythrocytes is the spectrin-ankyrin membrane skeleton continuous and homogeneous. In other cells, including neurons, wide variations exist within the cell in terms of the membrane organization of spectrin or ankyrin, both in terms of its uniformity and composition, and in whether spectrin and/or ankyrin are even associated with the plasma membrane or localized on internal compartments (De Matteis and Morrow, 2000) . When spectrin is concentrated at the membrane, it is most often at sites of specialized receptor function such as pre-and post-synaptic densities, rather than at sites that one would anticipate are subjected to high mechanical stress. However, recent data Journal of Cell Science 124 (0) 8 suggesting that spectrin might function as a mechanochemical signal transducer (Stabach et al., 2009 ) raises a speculative but interesting possibility that could reconcile the apparent fragility of spectrin-deficient axons (as observed in C. elegans) with the emerging role of spectrin as a major receptor-sorting and organizing scaffold. If stretch or bending of axons is a tropic stimulus for neuronal extension and maintenance (Van Essen, 1997) , then the absence of such stimulus might activate pathways to prune unwanted axons and dendrites (Luo and O'Leary, 2005) . If indeed a spectrin lattice is part of a mechanosensing pathway by which tension, stretch or bending is transduced to trophic signals, the absence of spectrin might leave neurons poised for degradation and pruning not by a mechanical instability, but rather because of an absence of maintenance signals.
Finally, it is worthwhile to consider the contributions of another major function of the spectrin-ankyrin skeleton to the pathology of the Spna2 2/2 animals. Based on studies in cultured cells, gene deletion studies, and linkage analysis of human diseases, it is well established that a key function of the spectrinankyrin skeleton is to facilitate the movement of selected membrane proteins through the secretory and endocytic pathways to points of physiologic action (reviewed in De Matteis and Morrow, 2000; Bennett and Healy, 2008) . Thus, patients with mutations in ankyrin B mis-sort voltage-gated sodium channels in heart muscle suffer from long QT syndrome type 4 and sudden cardiac death. Many other proteins also depend on ankyrin for efficient sorting, including the IP3 receptor (Tuvia et al., 1999) and aI-Na,K-ATPase (Stabach et al., 2008) . In lymphocytes, the trafficking of receptors CD3 and CD45 are both spectrin-and ankyrin-dependent (Pradhan and Morrow, 2002) . Mutations in bIII-spectrin cause spinocerebellar ataxia type 5 in humans (Ikeda et al., 2006) (and ataxia and seizures in mice) Stankewich et al., 2010) due to impaired intracellular transport of EAAT4 and at least five other proteins associated with the synapse Stankewich et al., 2010) . Thus, given that the Spna2 2/2 mice are deficient in and mis-localize their ankyrins and bII-and bIII-spectrin, it is likely that in these animals there are also problems with membrane protein organization and sorting. In future studies it will be important to examine this question in detail, both in vivo and in cultured cells, to identify the full repertoire of proteins that depend on spectrin and ankyrin for their efficient sorting to the correct membrane compartment.
Materials and Methods
Generation of C57BL/6 (Spna2
The embryonic stem (ES) cell line RRQ171 (BayGenomics, http://www.genetrap. org) was generated by gene -trap protocol with pGTOLxf, containing a spliceacceptor sequence subcloned 59 end of a b-geo reporter cassette encoding a b-galneomycin resistance fusion protein. ES cells heterozygous for the targeted mutation were microinjected into C57BL/6 blastocysts and implanted into pseudopregnant foster mothers. Male chimeras were mated with C57BL/6 females. Ten backcrosses established the gene-trapped allele on a C57BL/6 background. Mice were genotyped by quantitative RT-PCR using primers bridging the b-geo insertion and wild-type Spna2 sequence. The PCR primer sets used for detection of the exon trap were: 59-CAAATGGCGATTACCGTTGA-39 and 39-GAC-AGTATCGGCCTCAGGAAGATCG-59. Spectrin primers used were exon 6 sense; exon 7 reverse; exon 54 sense and exon 55 reverse. All animal experiments were performed according to the relevant regulatory standards.
Analysis of mRNA and protein expression
Embryos were harvested from pregnant heterozygous mice typically at E13.5 to E14.5. The levels of aII, bII, bIII, bIV, and bV-spectrin mRNA expression were measured by real-time PCR, using primers summarized in supplementary material Table S1 . For western blot analysis, embryos were homogenized in 3.0 ml extract buffer (20 mM HEPES pH 7.4, 120 mM NaCl, 25 mM KCl, 2 mM EDTA, 1 mM EGTA, 1% Triton X-100) supplemented with Protease Arrest (Calbiochem) (1:200). Supernatants were cleared at 28,000 g for 10 minutes at 4˚C, analyzed by SDS-PAGE (NUPAGE Gel System, Invitrogen). Antibodies were mouse monoclonal antibodies to aII-spectrin (Chemicon-clone 1622, and Santa Cruz Biotechnology clone C-11), bII-spectrin (Pharmingen), b-actin clone AC-74 (Sigma), and b-galactosidase (Developmental Studies Hybridoma Bank). Rabbit polyclonals were: aII-spectrin (Raf-A) and aI/bI-spectrin (Ras-C) (Harris et al., 1985) , ankyrin R (Cianci et al., 1988) , bIII-spectrin (Stankewich et al., 1998) , GFP (Clontech), bIV-spectrin (a gift from Michele Solimena, Technical University, Dresden, Germany). Other antibodies included anti-ankyrins B and G, rabbit anti-VASP (sc-13975); mouse anti-pan14-3-3 (sc-1657); rabbit anti-Abi (sc-30038), all from Santa Cruz Biotechnology. Transduction Labs provided mouse anti-KAP3 (K55520) and Cell Signaling provided mouse anti-Tau (4019). All antibodies were used at 1:1000 dilutions for western blot analysis except that actin Mab was used at 1:20,000. For western blot analysis, protein loadings were calculated so as to equalize the total protein load for each sample. This generally gave comparable levels of actin loading, which served as an internal marker. Each lane of each western blot represents a replicate sample from a different embryo.
Gradient sedimentation
Whole fresh E11.5 embryos were homogenized at 4˚C in 1 ml of homogenization buffer (20 mM HEPES pH 7.4, 120 mM NaCl, 25 mM KCl, 2 mM EDTA, 1 mM EGTA, 0.5% Triton X-100) supplemented with Protease Arrest (Calbiochem). After centrifugation (1000 g for 10 minutes) to remove tissue debris, homogenates were applied to a 5-20%, 13.5 ml continuous sucrose gradient and spun in a SW-40 rotor (Beckman) at 40,000 rpm for 22.5 hours. Aliquots of 0.5 ml were decanted from the top of the gradient mechanically using a gradient fractionator (Labconco). The refractive index, which correlates with density, of all fractions was analyzed with a refractometer.
Histology and immunolabeling
Immunoperoxidase staining of whole-mount embryos in paraffin sections was carried out as before (Stankewich et al., 2006) . Primary antibodies were used at a 1:500 dilution. For immunofluorescence, after the application of the primary antibody, sections were incubated with either goat anti-mouse or anti-rabbit secondary antibodies conjugated to Alexa Fluor dyes (Invitrogen) diluted 1:1000 for 1 hour at room temperature. To stain nuclei, slides were incubated in Hoechst dye 33342 for 10 minutes. For visualization by alkaline phosphatase, the EnVision G|2 reagent kit (Dako) was used in combination with Ferangi Blue (Biocare Medical). Tissues were counterstained with Nuclear Fast Red (PolyScientific). Slides were viewed by bright-field or fluorescent microscopy using an Olympus AX70 microscope; image acquisition was processed using OpenLab software (Improvision, Lexington, MA).
Analysis of primary mouse skin embryonic fibroblasts
Wild-type and Spna2 2/2 MEFs were harvested at E14.5 from embryos of heterozygous crosses, and established in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS). All experiments were duplicated in at least three independently established lines at passage numbers 3-9. All cell lines were individually genotyped. For cell growth assays, 2610 4 MEF cells were plated into each well of a 24-well Falcon tissue culture plate. Cells were grown at 37˚C; at each time point cells were suspended in 0.05% trypsin-EDTA and counted on an Improved Neubauer hemocytometer (each data point represents an average of six samples). To test TGF-b1 stimulation, NIH3T3 cells and MEF cells were grown and maintained in DMEM with 10% FBS (complete DMEM). Cells were plated at 70-80% confluence in complete DMEM. After 24 hours, culture media was exchanged with DMEM supplemented with only 1% FBS for 6 hours, then mouse TGF-b1 (Cell Signaling 5231) was added at 0, 2.5 or 10 ng/ ml for 24 and 48 hours. Cells were subsequently solubilized in gel loading buffer and proteins analyzed by western blot analysis. Antibodies used were rabbit antiSmad2/3 and phospho-Smad2 (S465/467) (Cell Signaling s3102 and138D4, respectively); mouse monoclonal anti-Smad3 (Santa Cruz Biotechnology sc-101154); mouse monoclonal anti-Smad4 (Santa Cruz Biotechnology sc-7966); and anti-Smad7, a gift from Mark Kidd (Yale University, New Haven, CT).
Cell spreading
MEFs were plated onto cover slips coated with 10 mg/ml fibronectin (Santa Cruz sc-29011). After 1-3 hours, cells were fixed with 3.0% formaldehyde and stained with Alexa Fluor 488-phallodin (Invitrogen). Images were captured and processed as above. From each analysis, 500 cells were randomly selected for evaluation. The relative area of the spread cells in both control and Spna2 2/2 MEFs was measured using the Photoshop CS magic wand tool to score pixel number within their well-defined cell borders. For recovery experiments, MEFs were transiently transfected with Lipofectamine 2000 mixed with plasmid encoding fluorescently tagged full-length aII-spectrin according to the manufacturer's instructions (Invitrogen). The pEYFP-aII-spectrin was prepared by subcloning a Deletion of aII-spectrin 9
complementary DNA (cDNA)-encoding full-length human aII-spectrin (GenBank U83867) into the pEYFP-C1 vector (Clontech), and was then shuttled into the pPRIPu vector (Street et al., 2006) .
